Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty

Autor: Lars Grip, Freek W.A. Verheugt, Lambert F.M. van den Merkhof, Maarten L. Simoons, Frits W. Bär, Hans Olsson, Gerrit Veen, Marcel van den Brand, Felix Zijlstra

Publikováno v: Journal of the American College of Cardiology, 33, 1528-1532
Journal of the American College of Cardiology, 33(6), 1528-1532. Elsevier Inc.
Journal of the American College of Cardiology, 33, 6, pp. 1528-1532

OBJECTIVES We sought to study the effect of early infusion of abciximab on coronary patency before primary angioplasty in patients with acute myocardial infarction. BACKGROUND Glycoprotein IIb/IIIa antagonists have proved to be effective in reducing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ff25000d871d15d53988bad5aa5975
https://doi.org/10.1016/s0735-1097(99)00038-8

Circumstances of death in adult congenital heart disease

Autor: Petronella G. Pieper, Diederick E. Grobbee, Luc Cozijnsen, Enno T. van der Velde, Leo H. B. Baur, Tieneke J.M. Ansink, Cuno S.P.M. Uiterwaal, Barbara J.M. Mulder, Ilonca Vaartjes, Folkert J. Meijboom, Lambert F.M. van den Merkhof, A. Carla Zomer

Publikováno v: International Journal of Cardiology, 154(2), 168-172
International journal of cardiology, 154(2), 168-172. Elsevier Ireland Ltd
International Journal of Cardiology, 154(2), 168-172. ELSEVIER IRELAND LTD

Background: Circumstances of death have been described for various cardiovascular diseases, but this study is the first for adults with congenital heart disease (CHD). Methods: Review of medical records and additional information from treating cardio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd2be943fbd715e5d688081f8767fb0
https://pubmed.ncbi.nlm.nih.gov/20934226